BioSpace News Archive

Filterlex Medical, a cardiovascular medical device startup, announced that it has recently completed a US $6 Million series A1 investment round from leading private healthcare investors.

GT Medical Technologies, Inc. a company dedicated to improving the lives of patients with brain tumors, today announced upcoming presentations related to its breakthrough GammaTile® Therapy at the 26th Annual Meeting of the Society for Neuro-Oncology (SNO) being held in Boston November 18-21, 2021.

Investigators in a major clinical trial of patients with mild traumatic brain injury (mTBI, or concussion) describe for the first time objective diagnostic criteria, based on blood biomarkers and neurologic testing, for acute traumatic encephalopathy (ATE), the immediate physiologic consequence the injury.

Rockley Photonics, a global leader in photonics-based health monitoring and communications solutions, formed a strategic relationship to incorporate Rockley’s non-invasive biomarker sensing platform into potential clinical and healthcare research studies.

Gemina Laboratories Ltd. is pleased to announce the appointment of Professor Michael Catt as Senior Scientific Adviser to the Company.

Amyris, Inc. announced that it will host a conference call and live webcast to discuss its recent financing activity on Monday, November 22, 2021 beginning at 6:00 a.m. Pacific Time, John Melo, President and Chief Executive Officer, and Han Kieftenbeld, Chief Financial Officer, will discuss the Company’s recent strategic financing.

LifeSprout, Inc., a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, announced the appointment of Michael Kranda as CEO and member of the board of directors.

Cellevolve Bio, a development and commercialization company focused on cell therapies, announced its launch following the successful close of seed financing and an exclusive manufacturing partnership with National Resilience, Inc., a biopharmaceutical manufacturing company supply.

Gilead Sciences, Inc. announced that its executives will be speaking at the following investor conference.

Labcorp today announced that it has entered into a definitive agreement to acquire Toxikon, a contract research organization delivering best-in-class nonclinical testing services.